pathscan total her3 erbb3 sandwich elisa kit Search Results


92
Cell Signaling Technology Inc phosphorylated protein levels
FIGURE 6 The combined suppression of HER2 signaling by tucatinib and T-DM1 is associated with reduced tumor growth. A, ELISAs quantifying phosphorylation of signaling components downstream of HER2 in BT-474 cells (as percentage <t>phosphorylated</t> protein vs. untreated cells with SEMs). B, IHC images of pHER2, pHER3, pAKT, and pMEK staining of the BT-474 xenograft tumor model. Inlay images represent HER2-stained tumor
Phosphorylated Protein Levels, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated protein levels/product/Cell Signaling Technology Inc
Average 92 stars, based on 1 article reviews
phosphorylated protein levels - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

91
Cell Signaling Technology Inc elisa phospho erbb3 levels
FIGURE 6 The combined suppression of HER2 signaling by tucatinib and T-DM1 is associated with reduced tumor growth. A, ELISAs quantifying phosphorylation of signaling components downstream of HER2 in BT-474 cells (as percentage <t>phosphorylated</t> protein vs. untreated cells with SEMs). B, IHC images of pHER2, pHER3, pAKT, and pMEK staining of the BT-474 xenograft tumor model. Inlay images represent HER2-stained tumor
Elisa Phospho Erbb3 Levels, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa phospho erbb3 levels/product/Cell Signaling Technology Inc
Average 91 stars, based on 1 article reviews
elisa phospho erbb3 levels - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

Image Search Results


FIGURE 6 The combined suppression of HER2 signaling by tucatinib and T-DM1 is associated with reduced tumor growth. A, ELISAs quantifying phosphorylation of signaling components downstream of HER2 in BT-474 cells (as percentage phosphorylated protein vs. untreated cells with SEMs). B, IHC images of pHER2, pHER3, pAKT, and pMEK staining of the BT-474 xenograft tumor model. Inlay images represent HER2-stained tumor

Journal: Cancer Research Communications

Article Title: HER2-selective and reversible tyrosine kinase inhibitor tucatinib potentiates the activity of T-DM1 in preclinical models of HER2-positive breast cancer

doi: 10.1158/2767-9764.crc-23-0302

Figure Lengend Snippet: FIGURE 6 The combined suppression of HER2 signaling by tucatinib and T-DM1 is associated with reduced tumor growth. A, ELISAs quantifying phosphorylation of signaling components downstream of HER2 in BT-474 cells (as percentage phosphorylated protein vs. untreated cells with SEMs). B, IHC images of pHER2, pHER3, pAKT, and pMEK staining of the BT-474 xenograft tumor model. Inlay images represent HER2-stained tumor

Article Snippet: Phosphorylated protein levels were normalized to total protein levels (ErbB2, #7310;HER3, #7888C; AKT, #7170C; MEK, #7165C all from CST) and quantified relative to untreated cells.

Techniques: Phospho-proteomics, Staining